China’s NMPA Officially Seeks Membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S)
The Pharmaceutical Inspection Co-operation Scheme (PIC/S) has announced that China’s National Medical Products Administration (NMPA)...
Policy / Regulatory
9th National Volume-Based Procurement Round Results in 70% Price Reduction for 41 Drugs
The results of the 9th round of China’s national volume-based procurement (VBP) program have been...
Guangxi HSA Expands Coverage for Assisted Reproductive Medical Services Under BMI
The Healthcare Security Administration (HSA) bureau of the Guangxi Zhuang Autonomous Region has announced a...
China’s Health Authorities Release Third List of 41 Drugs for Recommended Generic Development
The National Health Commission (NHC), National Healthcare Security Administration (NHSA), National Medical Products Administration (NMPA),...
NMPA Unveils 73rd Batch of Reference Drugs for Generic Quality Consistency
China’s National Medical Products Administration (NMPA) has released the 73rd batch of reference drugs as...
CDE Releases 75th Batch of Generic Reference Preparations with Updated Specifications
The Center for Drug Evaluation (CDE) has announced the release of the 75th batch of...
Peking University Unveils National Standardized Pain Treatment Center in China
Peking University People’s Hospital has officially unveiled the plaque for the National Standardized Pain Treatment...
NMPA Implements New Measures for Drug Manufacturing Outsourcing by MAHs
The National Medical Products Administration (NMPA) has issued a notice detailing new supervision and management...
National VBP Tender Program Invites Drugs Approved Before October 30 for Round 9
The National Allied Procurement Office has released a notification regarding Round 9 of the national...
China’s State Council Unveils Plan to Boost Patent Commercialization by 2025
China’s State Council has recently approved the “Special Action Plan for Patent Commercialization and Utilization...
NMPA Issues Guidelines for Temporary Import of Urgently Needed Medical Devices
The National Medical Products Administration (NMPA) has released new “Management Requirements for Temporary Import and...
China’s 9th National VBP Round Sets Rules for 42 Drugs Tender
The national drug alliance procurement office has issued a notification detailing the tendering rules for...
NMPA Announces Pathway for Developing Generic Drugs Without Reference Preparation
The National Medical Products Administration (NMPA) has issued an announcement regarding the development of generic...
China’s New Drug Quality Management Measures to Take Effect in 2024
The State Administration for Market Regulation (SAMR) has released the “Drug Operation and Use Quality...
Fujian’s Fourth Round VBP Seeks Public Feedback on Drug Procurement List
The Fujian drug and device joint procurement center has published the “Fujian Fourth Round Drug...
China Introduces Trial Measures for Science and Technology Ethics Review
The National Health Commission, Ministry of Science and Technology, Ministry of Education, and eight other...
China Releases First Supplement to 2020 Pharmacopoeia with 47 New Drug Varieties
The National Medical Products Administration (NMPA) and the National Health Commission have announced the release...
China’s Healthcare Landscape: Key Insights from the 2022 Statistical Communique
The National Health Commission (NHC) has released “China’s Healthcare Statistical Communique 2022,” providing a comprehensive...
Hainan Implements New Regulations for Import Drugs and Medical Devices in Medical Tourism Zone
The Hainan Medical Products Administration, in conjunction with Hainan’s Health Commission Bureau, has unveiled a...
NHSA Completes Expert Review for National Reimbursement Drug List Updates
The National Healthcare Security Administration (NHSA) has announced the completion of the expert review stage...